STOCK TITAN

Insider to sell 114,000 shares in company (NASDAQ: DVAX) filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock in DVAX has filed a notice of proposed sale under Rule 144. The filing covers a planned sale of 114,000 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an indicated aggregate market value of $1,782,726.80. These shares were acquired from the issuer on the same day through a stock option exercise paid in cash.

The notice also reports that the same seller, identified as David Novack, sold 30,000 common shares on 12/24/2025 for gross proceeds of $464,700.00. The issuer had 117,424,968 common shares outstanding at the time indicated, providing context for the size of the planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DVAX Rule 144 filing disclose about planned share sales?

The filing discloses a planned sale of 114,000 common shares of the issuer on NASDAQ, with an aggregate market value of $1,782,726.80, to be executed through Morgan Stanley Smith Barney LLC.

Who is selling shares in the DVAX Rule 144 notice and how many?

The seller is identified as David Novack, who has filed to sell 114,000 common shares and previously sold 30,000 common shares on 12/24/2025.

How were the DVAX shares to be sold under Rule 144 acquired?

The 114,000 common shares to be sold were acquired on 01/15/2026 from the issuer via a stock option exercise, with the purchase price paid in cash the same day.

What prior DVAX share sales are reported in the last three months?

The notice reports that David Novack sold 30,000 common shares on 12/24/2025, generating gross proceeds of $464,700.00.

How many DVAX shares are outstanding compared with the planned Rule 144 sale?

The issuer has 117,424,968 common shares outstanding, which provides context for the planned sale of 114,000 shares under Rule 144.

On which exchange will the DVAX shares in this Rule 144 filing be sold?

The planned sale of 114,000 common shares is listed to occur on the NASDAQ stock market.
Dynavax Technolo

NASDAQ:DVAX

DVAX Rankings

DVAX Latest News

DVAX Latest SEC Filings

DVAX Stock Data

1.78B
112.69M
0.6%
97.97%
12.02%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
EMERYVILLE